• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Geron Corporation (GERN)

    -NasdaqGS
    3.32 Up 0.09(2.79%) Jan 26, 4:00PM EST
    |After Hours : 3.32 0.00 (0.00%) Jan 26, 6:15PM EST
    Add to Portfolio
    Prev Close:3.23
    Open:3.25
    Bid:3.03 x 100
    Ask:N/A
    1y Target Est:4.63
    Beta:2.97
    Earnings Date:Mar 10 - Mar 16 (Est.)
    Day's Range:3.22 - 3.38
    52wk Range:1.31 - 5.24
    Volume:2,160,174
    Avg Vol (3m):5,142,050
    Market Cap:521.94M
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNUp 2.79%521.94M
    BMYUp 0.63%103.61B
    GSKUp 0.40%108.64B
    NVSDown 0.39%233.38B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):423.16
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.12
    Quarterly EPS Est (Dec-14) :0.05
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-5.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback